2018 Guidelines for the management of dyslipidemia - PubMed (original) (raw)
Review
. 2019 Jul;34(4):723-771.
doi: 10.3904/kjim.2019.188. Epub 2019 Jul 1.
Hyeon Chang Kim 2, Jae Hyeon Kim 3, Eun Young Lee 4, Byung Jin Kim 5, Eun Mi Kim 6, YoonJu Song 7, Jeong Hyun Lim 8, Hae Jin Kim 9, Seonghoon Choi 10, Min Kyong Moon 11, Jin Oh Na 12, Kwang-Yeol Park 13, Mi Sun Oh 14, Sang Youb Han 15, Junghyun Noh 16, Kyung Hee Yi 17, Sang-Hak Lee 18, Soon-Cheol Hong 19, In-Kyung Jeong 20
Affiliations
- PMID: 31272142
- PMCID: PMC6610190
- DOI: 10.3904/kjim.2019.188
Review
2018 Guidelines for the management of dyslipidemia
Eun-Jung Rhee et al. Korean J Intern Med. 2019 Jul.
Erratum in
- 2018 Guidelines for the management of dyslipidemia in Korea.
Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, Song Y, Lim JH, Kim HJ, Choi S, Moon MK, Na JO, Park KY, Oh MS, Han SY, Noh J, Yi KH, Lee SH, Hong SC, Jeong IK; Committee of Clinical Practice Guideline of Korean Society of Lipid and Atherosclerosis. Rhee EJ, et al. Korean J Intern Med. 2019 Sep;34(5):1171. doi: 10.3904/kjim.2019.188.e1. Epub 2019 Aug 28. Korean J Intern Med. 2019. PMID: 31466435 Free PMC article. No abstract available.
No abstract available
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Figure 1.
Trends of cardio-cerebrovascular mortality among Koreans, 1983 to 2016 (source: cause of death statistics). (A) Mortality rate (not age-adjusted). (B) Age-adjusted mortality rate (with reference to 2005 population).
Figure 2.
Trends of coronary artery disease mortality among Koreans, 1983 to 2016 (source: cause of death statistics). (A) Mortality rate (not age-adjusted). (B) Age-adjusted mortality rate (with reference to 2005 population).
Figure 3.
Trends of cerebrovascular disease mortality among Koreans, 1983 to 2016 (source: cause of death statistics). (A) Mortality rate (not age-adjusted). (B) Age-adjusted mortality rate (with reference to 2005 population).
Figure 4.
Serum lipid concentrations by age, sex, and menopause in Korean general population. (A) Total cholesterol, (B) low density lipoprotein cholesterol (LDL-C), (C) triglyceride, and (D) high density lipoprotein cholesterol (HDL-C) (data source: Korea National Health and Nutrition Examination Survey 2010 to 2016) [20].
Figure 5.
Trends in prevalence of hypercholesterolemia (A, source: National Health and Nutrition Examination Survey [KNHANES] 2005 to 2016) and sex and age-specific prevalence of dyslipidemia (B, source: KNHANES 2010 to 2012) [21,22].
Figure 6.
Trends in hypercholesterolemia management (source: National Health and Nutrition Examination Survey).
Figure 7.
Dietary guideline for prevention and treatment dyslipidemia.
Figure 8.
Drug therapy strategy for hypercholesterolemia. LDL-C, low density lipoprotein cholesterol.
Figure 9.
Comparison of low density lipoprotein cholesterol (LDL-C) reduction effects of statins between foreigners and Koreans [75,96]. Modified from Cholesterol Treatment Trialists’ Collaboration et al. [27].
Figure 10.
Korean data on the lipid-controlling efficacy of currently used statins [75,94]. LDL-C, low density lipoprotein cholesterol.
Figure 11.
Dyslipidemia treatment algorithm in children and adolescents. LDL-C, low density lipoprotein cholesterol; TG, triglyceride; CHILD, Cardiovascular Health Integrated Lifestyle Diet; FLP, fasting lipid profile; CVD, cardiovascular disease; HDL-C, high density lipoprotein cholesterol.
References
- World Health Organization . Geneva: World Health Organization; c2019. Global Health Observatory (GHO) data [Internet] [cited 2019 Jun 20]. Available from: http://www.who.int/gho/ncd/mortality_morbidity/ncd_total/en/index.html.
- World Health Organization . Geneva: World Health Organization; c2019. Preventing chronic diseases: a vital investment [Internet] [cited 2019 Jun 20]. Available from: http://www.who.int/chp/chronic_disease_report/en.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical